Lessons from transmissible cancers for immunotherapy and transplant

Immunol Med. 2022 Sep;45(3):146-161. doi: 10.1080/25785826.2021.2018783. Epub 2021 Dec 28.

Abstract

The emergence of horizontal transmission of cancer between vertebrates is an issue that interests scientists and medical society. Transmission requires: (i) a mechanism by which cancer cells can transfer to another organism and (ii) a repressed immune response on the part of the recipient. Transmissible tumors are unique models to comprehend the responses and mechanisms mediated by the major histocompatibility complex (MHC), which can be transposed for transplant biology. Here, we discuss the mechanisms involved in immune-mediated tissue rejection, making a parallel with transmissible cancers. We also discuss cellular and molecular mechanisms involved in cancer immunotherapy and anti-rejection therapies.

Keywords: MHC; Transmissible cancer; immunotherapy; transplant.

Publication types

  • Review

MeSH terms

  • Animals
  • Histocompatibility Antigens
  • Immunologic Factors
  • Immunotherapy*
  • Major Histocompatibility Complex
  • Neoplasms* / genetics
  • Neoplasms* / therapy

Substances

  • Histocompatibility Antigens
  • Immunologic Factors